Objective: To examine antenatal screening as a predictor of intrapartum shedding of herpes simplex virus (HSV) and to determine its usefulness in guiding the appropriate route of delivery for patients with recurrent HSV in pregnancy.
eonatal herpes simplex virus (HSV) infection is largely acquired intrapartum and, even with prompt recognition and treatment, is associated with significant morbidity and mortality. [1] [2] [3] Maternal infection is unrecognized in the majority of cases. 4,s In an attempt to reduce the incidence of this disease, the American Academy of Pediatrics in 1980 recommended serial viral screening in the last weeks of pregnancy for all women with a past history of genital herpes. 6 Figure 1 , the ability of an antepartum culture positive for HSV to predict a subsequent positive result (i.e., positive predictive value) was 59% (30/51) when the interval between visits was -<2 days, but only 19% (53/257) when days between visits were >2 (P < 0.0001). Clinical evidence of HSV was less predictive of a subsequent positive culture result. When the interval between visits was -<2 days, clinical prediction of a positive culture (i.e., positive predictive value) was 40% (27/67), whereas it was 17% (59/355) for >2 days (P < 0.0001).
At the final antenatal visit before labour, symptoms were reported in 13.6%, whilst signs of HSV were evident in 15.8%, and cultures were positive in 8.4% (Table 2) (P < 0.001) ( Table 4 ). There were no cases of neonatal herpes detected, and all baby and placental swabs taken at delivery were negative by viral culture.
DISCUSSION
In this patient population with histories of recurrent genital herpes, the observed culture-positivity rate for HSV for the 6-week period prior to delivery was consistently high, ranging from 11% to 19.5%.
An unexpected finding in this study was the low culture-positivity rate when nonspecialized personnel took genital swabs for culture. This unanticipated occurrence confounded the intrapartum cul- Finally, it is essential to recognise that current medical practice does not directly address the group at highest risk for neonatal transmission: HSV-susceptible women in the third trimester who are in HSV discordant relationships. 9 Only routine serologic screening of both partners can begin to address prevention in this highest-risk patient.
